The maternal-fetal transfer of lamivudine in the ex vivo human placenta
- 28 February 1997
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 176 (2), 291-293
- https://doi.org/10.1016/s0002-9378(97)70487-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic MillimeterNew England Journal of Medicine, 1995
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994
- The transfer of the nucleoside analog ganciclovir across the perfused human placentaAmerican Journal of Obstetrics and Gynecology, 1994
- The ex vivo Transfer of the Anti-HIV Nucleoside Compound d4T in the Human PlacentaGynecologic and Obstetric Investigation, 1994
- The transfer of anti-human immunodeficiency virus nucleoside compounds by the term human placentaAmerican Journal of Obstetrics and Gynecology, 1992
- The safety and pharmacokinetics of a reverse transcriptase inhibitor, 3TC, in patients with HIV infectionAIDS, 1992
- Effects of (-)-2'-deoxy-3'-thiacytidine (3TC) 5'-triphosphate on human immunodeficiency virus reverse transcriptase and mammalian DNA polymerases alpha, beta, and gammaAntimicrobial Agents and Chemotherapy, 1992
- Transfer of Zidovudine (AZT) by Human PlacentaThe Journal of Infectious Diseases, 1990